These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11100763)

  • 1. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
    Lee YC; Wu CT; Chen CS; Chang YL
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
    Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
    Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
    Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
    Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
    Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
    Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
    Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.
    Shimizu K; Yoshida J; Nagai K; Nishimura M; Ishii G; Morishita Y; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):160-5. PubMed ID: 15999057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
    Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of plakoglobin in bronchial carcinomas: incidence and significance for disease outcome].
    Passlick B; Pantel K; Stosiek P; Hosch S; Thetter O; Izbicki JR
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():810-3. PubMed ID: 9101995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.
    Zhong LP; Li J; Zhang CP; Zhu HG; Sun J; Zhang ZY
    Arch Oral Biol; 2007 Aug; 52(8):740-7. PubMed ID: 17331461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker.
    Sayar A; Turna A; Solak O; Kiliçgün A; Urer N; Gürses A
    Ann Thorac Surg; 2004 Feb; 77(2):421-5. PubMed ID: 14759409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
    Ono K; Uramoto H; Hanagiri T
    Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
    Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
    J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.